CURRENT MICROBIOLOGY, published by SPRINGER, is a renowned journal that serves as a critical platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0343-8651 and an E-ISSN of 1432-0991, this journal contributes significantly to the scientific community by covering a diverse range of topics from applied microbiology and biotechnology to various aspects of medicine. Currently operating an impact factor that places it within the Q2 quartile in both applied microbiology and biotechnology and medicine (miscellaneous), along with a Q3 ranking in microbiology, CURRENT MICROBIOLOGY is recognized for its valuable contributions to these dynamic fields. This journal, which has documented the evolution of microbiological research since its inception in 1978, provides an essential venue for researchers, professionals, and students alike to explore innovative studies and advances. Although it does not offer open access, the journal remains a pivotal resource within its category, complementing the ongoing growth and exploration of microbiology from its headquarters at One New York Plaza, Suite 4600, New York, NY 10004, United States. Its Scopus rankings highlight its reputable standing, making it a key publication for anyone aiming to stay at the forefront of microbiological science.

Indonesian Journal of Pharmacy (ISSN: 2338-9486; E-ISSN: 2338-9427), published by UNIV GADJAH MADA, FAC FARMASI, stands as a significant platform for disseminating pioneering research in the field of pharmacy and pharmacology. Since its transition to an Open Access format in 2011, the journal has enhanced its visibility and accessibility, catering to a global audience of researchers, practitioners, and students. With a commendable Q3 category ranking in Pharmaceutical Science, Pharmacology, and Pharmacy for 2023, along with its respectable Scopus ranks, it provides valuable insights and advancements in the pharmaceutical sciences, particularly relevant to the Indonesian context and beyond. The journal not only supports the academic community but also contributes to the enhancement of healthcare practices through rigorous peer-reviewed publications. By fostering knowledge exchange and collaboration, the Indonesian Journal of Pharmacy aims to play a pivotal role in advancing research and development in pharmacy-related disciplines.

FEMS Microbiology Letters, published by Oxford University Press, is a prestigious international journal dedicated to advancing the understanding of microbiology through concise and impactful research articles. With an ISSN of 0378-1097 and E-ISSN 1574-6968, this journal encompasses a wide range of topics within the fields of genetics, microbiology, and molecular biology, achieving a notable Q3 quartile ranking in these categories as of 2023. As an essential platform for researchers, professionals, and students, FEMS Microbiology Letters invites submissions that contribute valuable insights into microbial behaviors, genetic mechanisms, and innovative methodologies pivotal in the study of microbiology. Although it is not an open-access publication, the journal's rigorous editorial standards ensure high-quality content that is relevant and significant to its audience, furthering scholarly dialogue and collaboration in the vibrant field of microbiological research.

JOURNAL OF BASIC MICROBIOLOGY is a premier publication in the field of microbiology, published by WILEY since 1985. With a significant presence in Germany, this journal encompasses a wide spectrum of research topics, focusing on applied microbiology and biotechnology as well as diverse areas within medicine. Holding a commendable Q2 ranking in both its categories for 2023, it plays a crucial role in disseminating innovative findings and methodologies to the community. Researchers will find it to be an essential platform for sharing high-quality work, where it currently stands at rank #47 in the applied microbiology and biotechnology category, representing the 63rd percentile among international journals. The JOURNAL OF BASIC MICROBIOLOGY caters to a growing audience of professionals and students, offering insights essential for advancement in microbiological research and its applications. While it does not currently offer an Open Access option, it remains an influential outlet for academic excellence, continuously contributing to the development of the field through its rigorous peer-reviewed articles.

Journal of Pediatric Infection is a vital academic resource dedicated to the ever-evolving field of infectious diseases in pediatric populations. Published by AVES YAYINCILIK in Turkey, this journal features a rigorous peer-review process and has established itself as a platform for innovative research from around the globe. Although currently categorized in the Q4 quartile for both Infectious Diseases and Pediatrics, Perinatology and Child Health, the journal's potential for growth is substantial, attracting contributions that aim to shed light on the complexities of infectious diseases affecting children. With a converged publication history from 2009 to 2024, the journal emphasizes the importance of advancing knowledge in pediatric health through systematic reviews, original research, and case studies. Its open access policy encourages unrestricted sharing of vital research findings, making it an essential read for researchers, clinicians, and students dedicated to improving pediatric healthcare outcomes.

ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY, published by Springer, is a vital resource for advancing research in the fields of microbiology and molecular biology. With its ISSN 0003-6072 and E-ISSN 1572-9699, this journal consistently focuses on cutting-edge studies and developments, providing a platform for the dissemination of knowledge that spans over its rich history from 1934 onwards. The journal holds an impressive reputation, ranked Q2 in Medicine (miscellaneous) and Q3 in both Microbiology and Molecular Biology for 2023, reflecting its significant contribution to the scientific community. Researchers and professionals from various disciplines rely on this journal for quality publications that address complex microbial interactions and molecular mechanisms. Although it currently does not provide open access options, its compelling research remains accessible through institutional subscriptions, allowing it to foster collaborative advancements in the ever-evolving landscape of microbiological sciences.

Microbial Drug Resistance, published by MARY ANN LIEBERT, INC, is a pivotal journal that explores the critical intersection of microbiology and pharmacology with a keen focus on antibiotic resistance and related issues. Since its inception in 1995, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for innovative studies that inform the global response to antimicrobial resistance. With a commendable position in the Category Quartiles, ranked Q2 in Medicine (miscellaneous) and Q2 in Pharmacology for 2023, it caters to a multidisciplinary audience by addressing the implications of microbial resistance within various medical contexts. Although currently non-Open Access, the journal allows subscribers and institutions to access high-quality, peer-reviewed research, directly impacting policy and practice in healthcare settings. Committed to advancing our understanding and combating the challenges posed by resistant microbes, Microbial Drug Resistance remains an essential publication in the fields of microbiology, immunology, and pharmacology.

INDIAN JOURNAL OF MICROBIOLOGY, published by Springer, serves as a vital platform for the dissemination of cutting-edge research in the field of microbiology. With an ISSN of 0046-8991 and an E-ISSN of 0973-7715, this esteemed journal invites contributions that span various disciplines within microbiology, encompassing both fundamental studies and applied research that can impact health, environment, and industry. Recognized in the Q3 category in Microbiology for 2023, and ranking #80 out of 182 in Scopus’ Microbiology category, it reflects its commitment to quality and significance in the academic community. Authors and researchers benefit from the journal's comprehensive review process, which enhances the visibility and reach of their work. While no open access options are currently offered, the INDIAN JOURNAL OF MICROBIOLOGY remains a premier choice for those aiming to contribute to the ongoing dialogue in microbiological studies, ensuring that knowledge continues to evolve and thrive.

HELICOBACTER is a leading peer-reviewed journal published by Wiley, dedicated to advancing the field of gastroenterology and infectious diseases. With an impressive impact factor that places it in the Q1 quartile across three critical categories—gastroenterology, infectious diseases, and miscellaneous medicine—it signifies the journal's crucial role in disseminating high-quality research and fostering academic dialogue. Commencing publication in 1996, HELICOBACTER has established itself as a pivotal platform for innovative studies, case reports, and reviews, focusing on Helicobacter species and their clinical implications, thus attracting a global audience of researchers, healthcare professionals, and students eager to stay at the forefront of the field. Despite not being an open-access journal, its strong reputation is reinforced by its Scopus ranks, where it stands impressively at #19 out of 167 in gastroenterology, placing it in the 88th percentile among its peers. As a vital resource for those engaged in gastrointestinal and infectious research, HELICOBACTER continues to contribute significantly to the understanding and management of Helicobacter-related conditions.

Microbial Physiology is a premier, peer-reviewed journal published by KARGER, dedicated to advancing the field of microbiology through innovative research and reviews. With an ISSN of 2673-1665 and an E-ISSN of 2673-1673, the journal stands out in the academic landscape having established a strong track record since its inception in 2020, converging its scope until 2024. It proudly holds a Q2 category ranking in several key areas including Applied Microbiology and Biotechnology, Biochemistry, and Microbiology, making it an essential resource for researchers and professionals in these disciplines. The journal provides open access options to ensure that cutting-edge findings are widely disseminated, fostering collaboration and knowledge sharing. As a vital contributor to the ongoing discourse in microbial physiology, the journal serves as a platform for novel discoveries and methodologies that can significantly impact health, industry, and environmental sustainability. Located in Basel, Switzerland, it brings together a global community of scholars eager to further explore the complexities of microbial life.